-
公开(公告)号:DK2729217T3
公开(公告)日:2018-08-06
申请号:DK12735605
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
IPC: A61P27/02 , A23K20/179 , A23K50/75 , A23L15/00 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/155 , A23L33/16 , A61K31/047 , A61K31/07 , A61K31/202 , A61K45/06
-
公开(公告)号:NZ332408A
公开(公告)日:1999-08-30
申请号:NZ33240897
申请日:1997-05-30
Applicant: HOWARD FOUNDATION
Inventor: HOWARD ALAN , HARRIS ROGER
IPC: A23C9/123 , A23C20060101 , A23C9/13 , A23L20060101 , A23L1/30 , A23L1/305 , A23L2/00 , A23L2/38 , A23L2/39 , A23L2/52 , A61K20060101 , A61K31/195 , A61K31/198 , A61K31/4168
Abstract: Disclosed is an acidic composition for human consumption, comprising creatine. In particular the composition is conveniently an isotonic drink for storage at 4 DEG C., or is a dry stable powder which may be stored at ambient temperature.
-
公开(公告)号:ES2832734T3
公开(公告)日:2021-06-11
申请号:ES18167176
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
IPC: A61P27/02 , A23K20/179 , A23K50/75 , A23L15/00 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/155 , A23L33/16 , A61K31/047 , A61K31/07 , A61K31/202 , A61K45/06 , A61P43/00
Abstract: Un método no terapéutico de mejora del rendimiento visual de un sujeto humano sin degeneración macular relacionada con la edad que necesita dicha mejora, comprendiendo el método la etapa de administrar al sujeto una cantidad eficaz de una composición que comprende mesozeaxantina, luteína y zeaxantina como un complemento alimenticio o aditivo alimenticio, y en el que la realización del método mejora la sensibilidad de contraste en condiciones fotópicas.
-
公开(公告)号:DK3372280T3
公开(公告)日:2020-11-16
申请号:DK18167176
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
IPC: A61P27/02 , A23K20/179 , A23K50/75 , A23L15/00 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/155 , A23L33/16 , A61K31/047 , A61K31/07 , A61K31/202 , A61K45/06 , A61P43/00
-
公开(公告)号:GB2511406A
公开(公告)日:2014-09-03
申请号:GB201323003
申请日:2013-12-24
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: HOWARD ALAN , NOLAN JOHN , BEATTY STEPHEN
Abstract: A method of identifying a human subject, more likely than a subject selected at random from the general population, to have one or more of the following: (i) a low macular pigment concentration in the eye or eyes; (ii) a low visual performance, or (iii) an atypical central dip macular pigment distribution; the method comprising the steps of: measuring at least one cognitive function of the subject; comparing the measured cognitive function with a pre-determined threshold; and, if the measured cognitive function is below the threshold, declaring the subject as being more likely to have one or more of low macular pigment concentration in the eye or eyes, low visual performance or an atypical central dip macular pigment profile. The subject may be suspected or diagnosed as having Alzheimers disease.
-
公开(公告)号:CA2837047A1
公开(公告)日:2013-01-10
申请号:CA2837047
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
IPC: A61K31/045 , A23L1/30 , A23L15/00 , A23L33/15 , A23L33/155 , A61K31/07 , A61P27/02
Abstract: Disclosed is a composition comprising meso-zeaxanthin for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.
-
公开(公告)号:PL2729217T3
公开(公告)日:2018-10-31
申请号:PL12735605
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
IPC: A61P27/02 , A23K20/179 , A23K50/75 , A23L15/00 , A23L33/105 , A23L33/115 , A23L33/15 , A23L33/155 , A23L33/16 , A61K31/047 , A61K31/07 , A61K31/202 , A61K45/06
-
公开(公告)号:IE20130391A1
公开(公告)日:2014-09-10
申请号:IE20130391
申请日:2013-12-23
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , HOWARD ALAN
Abstract: A method of identifying a human subject, more likely than a subject selected at random from the general population, to have one or more of the following: (i) a low macular pigment concentration in the eye or eyes; (ii) a low visual performance, or (iii) an atypical ‘central dip’ macular pigment distribution; the method comprising the steps of: measuring at least one cognitive function of the subject; comparing the measured cognitive function with a pre-determined threshold; and, if the measured cognitive function is below the threshold, declaring the subject as being more likely to have one or more of low macular pigment concentration in the eye or eyes, low visual performance or an atypical ‘central dip’ macular pigment profile.
-
公开(公告)号:GB2503608A
公开(公告)日:2014-01-01
申请号:GB201317630
申请日:2013-10-04
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: HOWARD ALAN , NOLAN JOHN , BEATTY STEPHEN , THURNHAM DAVID
IPC: A61K31/07 , A23L1/30 , A23L15/00 , A23L33/15 , A23L33/155
Abstract: A composition comprises meso-zeaxanthin (MZ), lutein and zeaxanthin for use as a dietary supplement or food additive for oral consumption to improve contrast sensitivity, in a human subject with age-related macular degeneration (AMD). Preferably the ratio of MZ to lutein to zeaxanthin is about 10:10:2. Preferably the composition comprises one or more vitamins and/or minerals and may also comprise vegetable oil and/or fish oil and/or omega 3 fatty acid. A method of making a composition for human consumption, the composition to be consumed by a human subject with AMD for improving visual performance, the method comprising the step of mixing an effective amount of MZ with an acceptable dietary diluents, excipient or carrier is also outlined.
-
公开(公告)号:AU2012280056A1
公开(公告)日:2013-12-12
申请号:AU2012280056
申请日:2012-07-05
Applicant: HOWARD FOUNDATION HOLDINGS LTD
Inventor: NOLAN JOHN , BEATTY STEPHEN , LOUGHMAN JAMES , HOWARD ALAN , THURNHAM DAVID
Abstract: Disclosed is a composition comprising meso-zeaxanthin for use as a dietary supplement or food additive for oral consumption for improving the visual performance of a human subject.
-
-
-
-
-
-
-
-
-